Search

FOR IMMEDIATE RELEASE CONTACT David Cameron, Broad Institute dcameron@broadinstitute.org 617-714-7184 Janet Janjigian, Carmen Group janjigianj@carmengroup.com 424-354-0133 Merkin Prize honors Dr. Caruthers’ transformative work synthesizing DNA September 27, 2023 (Cambridge, MA.)—Dr. Richard Merkin...

October 31, 2025 Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Broad Institute for chimeric antigen receptor (CAR) T-cell therapy Produced by the Heritage Provider Network video team This groundbreaking form of personalized cancer immunotherapy...

July 25, 2024 2024 Merkin Prize in Biomedical Technology awarded to F. William Studier for T7 Technology [VIDEO] Produced by the Broad Institute of MIT and Harvard F. William Studier of Brookhaven National Laboratory has won the 2024 Richard N. Merkin Prize in Biomedical Technology for his...

Carl June University of Pennsylvania Perelman School of Medicine Carl June is the Richard W. Vague professor in immunotherapy at the Perelman School of Medicine at the University of Pennsylvania, where he is also the director of the Center for Cellular Immunotherapies. In addition, he is the...

FOR IMMEDIATE RELEASE CONTACT Karen Zusi-Tran Broad Institute kzusi@broadinstitute.org Janet Janjigian Heritage Provider Network janjigianj@carmengroup.com 424-354-0133 The winners are Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain, who developed technology that reprograms patients’...

This groundbreaking form of personalized cancer immunotherapy has had remarkable success — more than 45,000 cancer patients worldwide have been treated with CAR T-cell therapy, extending their lives and, in many cases, delivering complete and sustained remissions.

Nominations for the 2026 Merkin Prize have closed. Nominations for the 2027 Prize open in August 2026. Join the Merkin Prize mailing list to receive updates and notifications. Join mailing list